Hagenimana M, Green A, Tierney J, Lenert M, Burton M
Res Sq. 2025; .
PMID: 40034446
PMC: 11875293.
DOI: 10.21203/rs.3.rs-6058617/v1.
Karin J, Mintz R, Raveh B, Nitzan M
Nat Comput Sci. 2024; 4(12):941-954.
PMID: 39633094
PMC: 11659171.
DOI: 10.1038/s43588-024-00721-5.
Fogarasi M, Dima S
Cells. 2024; 13(20.
PMID: 39451194
PMC: 11506310.
DOI: 10.3390/cells13201676.
Sen S, Ali R, Onkar A, Verma S, Ahmad Q, Bhadauriya P
Commun Chem. 2024; 7(1):161.
PMID: 39043846
PMC: 11266353.
DOI: 10.1038/s42004-024-01241-z.
Hayashi T, Kanno S, Watanabe C, Scuteri D, Agatsuma Y, Hara A
Biomedicines. 2024; 12(6).
PMID: 38927539
PMC: 11202074.
DOI: 10.3390/biomedicines12061332.
Comparative study on muscle function in two different streptozotocin-induced diabetic models.
Aisyah R, Kamesawa M, Horii M, Watanabe D, Yoshida Y, Miyata K
Acta Diabetol. 2024; 61(11):1443-1453.
PMID: 38856757
PMC: 11531449.
DOI: 10.1007/s00592-024-02311-3.
GHSR Deletion in β-Cells of Male Mice: Ineffective in Obesity, but Effective in Protecting against Streptozotocin-Induced β-Cell Injury in Aging.
Han H, Pradhan G, Villarreal D, Kim D, Jain A, Gaharwar A
Nutrients. 2024; 16(10).
PMID: 38794702
PMC: 11123813.
DOI: 10.3390/nu16101464.
Improving Cutaneous Wound Healing in Diabetic Mice Using Naturally Derived Tissue-Engineered Biological Dressings Produced under Serum-Free Conditions.
Safoine M, Paquette C, Gingras G, Fradette J
Stem Cells Int. 2024; 2024:3601101.
PMID: 38737365
PMC: 11087150.
DOI: 10.1155/2024/3601101.
miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1.
Yu J, Liu H, Chen Y, Wang L, Chen P, Zhao Y
Diabetol Metab Syndr. 2024; 16(1):98.
PMID: 38715117
PMC: 11077876.
DOI: 10.1186/s13098-024-01322-y.
Immunopeptidome mining reveals a novel ERS-induced target in T1D.
Wang L, Yang S, Zhu G, Li J, Meng G, Chen X
Cell Mol Immunol. 2024; 21(6):604-619.
PMID: 38689020
PMC: 11143349.
DOI: 10.1038/s41423-024-01150-0.
Unveiling cell subpopulations in T1D mouse islets using single-cell RNA sequencing.
Yang H, Luo J, Liu X, Luo Y, Lai X, Zou F
Am J Physiol Endocrinol Metab. 2024; 326(5):E723-E734.
PMID: 38506753
PMC: 11376805.
DOI: 10.1152/ajpendo.00323.2023.
Animal models for type 1 and type 2 diabetes: advantages and limitations.
Singh R, Gholipourmalekabadi M, Shafikhani S
Front Endocrinol (Lausanne). 2024; 15:1359685.
PMID: 38444587
PMC: 10912558.
DOI: 10.3389/fendo.2024.1359685.
Assessing the effectiveness of Interleukin-2 therapy in experimental type 1 diabetes.
Luo Z, Mejia-Cordova M, Hamze N, Berggren E, Chopra S, Safi B
Endocrine. 2024; 85(2):626-637.
PMID: 38424350
PMC: 11291609.
DOI: 10.1007/s12020-024-03753-z.
Manifestation of Pathology in Animal Models of Diabetic Retinopathy Is Delayed from the Onset of Diabetes.
Cubillos S, Kazlauskas A
Int J Mol Sci. 2024; 25(3).
PMID: 38338889
PMC: 10855501.
DOI: 10.3390/ijms25031610.
Dapagliflozin Mitigated Elevated Disomic and Diploid Sperm in a Mouse Model of Diabetes and Recover the Disrupted , , and Gene Expression.
Albekairi N, Al-Hamamah M, Alshamrani A, Attia M, Nadeem A, Ansari M
Biomedicines. 2023; 11(11).
PMID: 38001980
PMC: 10669605.
DOI: 10.3390/biomedicines11112980.
Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy.
Pfeifer C, Walsh J, Santeford A, Lin J, Beatty W, Terao R
Proc Natl Acad Sci U S A. 2023; 120(45):e2308214120.
PMID: 37903272
PMC: 10636339.
DOI: 10.1073/pnas.2308214120.
Hepatic conversion of acetyl-CoA to acetate plays crucial roles in energy stress.
Wang J, Wen Y, Zhao W, Zhang Y, Lin F, Ouyang C
Elife. 2023; 12.
PMID: 37902629
PMC: 10615369.
DOI: 10.7554/eLife.87419.
Neuron-Schwann cell interactions in peripheral nervous system homeostasis, disease, and preclinical treatment.
Oliveira J, Yanick C, Wein N, Gomez Limia C
Front Cell Neurosci. 2023; 17:1248922.
PMID: 37900588
PMC: 10600466.
DOI: 10.3389/fncel.2023.1248922.
Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice.
Alshamrani A, Al-Hamamah M, Albekairi N, Attia M, Ahmad S, Assiri M
Biomedicines. 2023; 11(10).
PMID: 37893048
PMC: 10604863.
DOI: 10.3390/biomedicines11102674.
Identifying potential therapeutic targets of mulberry leaf extract for the treatment of type 2 diabetes: a TMT-based quantitative proteomic analysis.
Shi L, Wang J, He C, Huang Y, Fu W, Zhang H
BMC Complement Med Ther. 2023; 23(1):308.
PMID: 37667364
PMC: 10476348.
DOI: 10.1186/s12906-023-04140-3.
